MedPath

Prediction Model for Lateral Lymph Node Metastasis

Conditions
Rectal Cancer
Interventions
Procedure: lateral lymph node dissection
Registration Number
NCT04635488
Lead Sponsor
West China Hospital
Brief Summary

Mid to low-lying rectal cancer patient with enlarged lateral lymph node befor treatment and receiving lateral lymph node dissection would be enrolled. Radiomics parameters of lateral lymph nodes would be extracted by expert software. Then a part of the nodes would be used as the training set to build the prediction model, and the another part nodes would be used as the validation set.

Detailed Description

After performing lateral lymph node dissection for the enrolled patients, we would find the targeted lateral node which was matched with the enlarged one in imaging from the specimen. Then the nodes would be send for pathological examination. Then we would extract the radiomics parameters of the nodes from the pretreatment CT and MRI with ITK-SNAP software. According to the pathological status, lymph nodes and corresponding radiomics parameters would be divided into positive and negative groups. Then significant parameters would be selected by R software. Then the prediction model with nomogram would be developed. 70% nodes would be used for for model development and the other 30% would be used for validation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • middle to low-lying rectal adenocarcinoma patients with enlarged lateral lymph node ≥5mm for short diameter in CT and/or MRI
Exclusion Criteria
  • other kind of rectal tumor including neuroendocrine and malignant.
  • high location rectal cancer.
  • recurrent rectal cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Trainning grouplateral lymph node dissection70% of the whole participants would be randomly divided into the training group to build the predicition model.
validation grouplateral lymph node dissection30% of the whole participant would be divided into the validation group to validate the model
Primary Outcome Measures
NameTimeMethod
metastasis rate of lateral lymph node2020.1-2022.12.31
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Guoxue Road 37#,West China Hospital

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath